摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-{4-[(4,5-Dihydro-1H-imidazol-2-ylamino)methyl]phenoxy}-4-pyrimidinyl)-3-(4-fluorophenyl)propanoic acid

中文名称
——
中文别名
——
英文名称
3-(2-{4-[(4,5-Dihydro-1H-imidazol-2-ylamino)methyl]phenoxy}-4-pyrimidinyl)-3-(4-fluorophenyl)propanoic acid
英文别名
3-[2-[4-[(4,5-dihydro-1H-imidazol-2-ylamino)methyl]phenoxy]pyrimidin-4-yl]-3-(4-fluorophenyl)propanoic acid
3-(2-{4-[(4,5-Dihydro-1H-imidazol-2-ylamino)methyl]phenoxy}-4-pyrimidinyl)-3-(4-fluorophenyl)propanoic acid化学式
CAS
——
化学式
C23H22FN5O3
mdl
——
分子量
435.458
InChiKey
PVJXKEKEWWJIIL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    32
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    109
  • 氢给体数:
    3
  • 氢受体数:
    7

文献信息

  • PROPANOIC ACID DERIVATIVES AS INTEGRIN INHIBITORS
    申请人:CELLTECH THERAPEUTICS LIMITED
    公开号:EP1133488A1
    公开(公告)日:2001-09-19
  • US6319922B1
    申请人:——
    公开号:US6319922B1
    公开(公告)日:2001-11-20
  • [EN] PROPANOIC ACID DERIVATIVES AS INTEGRIN INHIBITORS<br/>[FR] DERIVES D'ACIDE PROPANOIQUE UTILISES EN TANT QU'INHIBITEURS DES INTEGRINES
    申请人:CELLTECH THERAPEUTICS LTD
    公开号:WO2000031067A1
    公开(公告)日:2000-06-02
    Propanoic acid derivatives of formula (1) are described: Ar-X1-Ar1-Z-R in which Ar is a nitrogen base containing group; X1 is linker atom or group; Ar1 is an optionally substituted 5- or 6-membered nitrogen-containing aromatic or non-aromatic monocycle; Z is a group -CH(R13)CH2- [in which R13 is an optionally substituted aliphatic, cycloaliphatic, heteroaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group], -C(R?12a)(R13)-CH(R12b¿)- [in which R?12a and R12b¿ together with the carbon atoms to which they are attached form a C¿3-7?cycloalkyl group] or C(R?13¿)=CH-; R is a carboxylic acid (-CO¿2?H) or a derivative or biostere thereof; and the salts, solvates, hydrates and N-oxides thereof. The compounds are able to inhibit the binding of αV integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
查看更多